Institutional Capital & Cannabis Europe
June 26, 2019
1120 Avenue of the Americas, 6th Floor, New York, NY 10036
IMN is excited to announce a new partnership with Prohibition Partners, Europe’s leading provider of market and strategic insights into the European legal cannabis markets. IMN and Prohibition Partners will co-host the first annual Institutional Capital & Cannabis Conference Europe (IC3 Europe), June 26, in London.
With over double the population of the US and Canada combined, Europe is expected to become the largest legal cannabis market in the world, within the next five to ten years. Some analysts are estimating that the European legal cannabis market will be worth €125 billion by 2028. The multijurisdictional nature of Europe makes it a complex market but lessons can be learned from regulated markets as industry players look to take advantage of the opportunities that exist.
IMN’s IC3 forums are a meeting place for investors who wish to invest or learn more about this exciting and high-growth new asset class, cannabis companies and investment funds who are looking to raise money or showcase their products, and professional service providers who facilitate these groups doing business.
Our US conferences have earned a reputation for quality content, expert speakers, and a high representation of institutional investors. Previous IC3 participants include leading cannabis brands Canndescent, MedMen, MedReleaf, Flow Kana, Tikun Olam and funds such as Privateer Holdings (Tilray, Marley Natural), Casa Verde (Eaze), Gotham Green Partners (Cronos), Merida Capital (KushCo) and a number of ex-Wall Street professionals turned private investors.
IMN is excited to bring this one-of-kind forum aimed at sophisticated investors seeking alternative asset classes and portfolio diversification to the UK this June.
Searching By Name/Company
To view your agenda you must be signed in
Wednesday, June 26th, 2019
Global State of the Industry and Market Outlook
It’s 2019 and the global cannabis industry is undergoing a rapid evolution. Last year saw the legalisation of recreational cannabis use in Canada, significant progress made at the state level in the US, and the introduction of legislation in a number of European nations. This session will look at the numbers, highlighting the most promising growth markets in Europe and abroad.
Investment Opportunities in Legal Cannabis
Update on the Regulatory Landscape in Europe
Significant legislative events in Europe were witnessed by the sector last year. The UK legalized the limited prescribed use of medical cannabis products and Germany has issued more tenders for domestic medical cannabis production. Despite this, considerable issues with access remain.
This unique panel will examine the legislative and regulatory status of medical and recreational cannabis across Europe, how these laws and regulations are being implemented, and what the major stumbling blocks are when setting up such frameworks.
The Path to Public Markets
Assessing the Upside of Investing in Europe
Europe is on track to become the world’s largest legal cannabis market within the next five years, with over €500million of investments into European cannabis companies in the last year and a forecasted market worth of up to €123billion by 2028. A well-regulated cannabis industry could bring significant benefits and opportunities to European economies. What do developments in North America and other markets mean for Europe?
How Wealth and Asset Managers Are Looking At Cannabis
Impact Investing: Medical Efficacy and Societal Impact of Legal Cannabis
More and more investors are looking to have an impact investing allocation in their portfolio. Social justice, regulatory reform and improving the overall health of our society make cannabis a prime fit for this allocation. This panel will address the socioeconomic benefits that a well-regulated cannabis industry can offer.
Due Diligence Best Practice for Cannabis Investments
Strategic Approaches to Building a Successful Cannabis Business
There are many different approaches to building a business but in the growing cannabis space, there are certain things that every business and investor needs to know. This session will address the importance of intellectual property (IP) and protection strategies, along with scaling and the major differences between businesses “touching the plant” and “not touching the plant”.
Intellectual Property and Innovation in the Cannabis Industry
This discussion will focus on the increasing presence of intellectual property (IP) within cannabis companies, ranging from allocation of value from operating entities to technology transfer issues with brand transactions. Learn about current trends to maximize both the value of IP assets and the latest trends in protection strategies.
From Theory to Reality: Invest Like the Best
Following a day of education and discussion, this session pulls it all together, and we hear from experienced investors and finance professionals who are already active in this exciting new asset class. Our panelists reveal firsthand accounts of where they've found success, hard lessons learned and pitfalls to be avoided, and key nuggets of advice they have for those considering investing in this space.
Crystal Balling the Future of Cannabis in Europe
After a full, solid day of discussion, where does this leave us? What has surprised us in the past year and what can we expect for the months and years ahead? Industry leaders from business and policy discuss legalisation, regulation and what this means for all of you.
To register for this conference you must be signed in
- Investor Super Early Bird * - £195
- Investor Early Bird * - £395
- Investor - £595
- Standard Super Early Bird - £795
- Standard Early Bird - £995
- Standard rate - £1,295
- On-site rate - £1,495
- Conference Venue
etc.venues, Liverpool Street - 155 Bishopsgate
Liverpool Street - 155 Bishopsgate
London, England, EC2M 3YD
Tel: +1(212)901-0506 Fax: +1(212)768-2484
View Full Site
You need to login before accessing this section. Click "Login" from bottom menu.